DR. MAKARY, DR OZ: People talk about lowering health care costs, but the Trump administration is doing it
FDA announces major reforms to streamline biosimilar approvals, potentially saving Americans billions on prescription drug costs by removing extra clinical trial requirements.
FDA announces major reforms to streamline biosimilar approvals, potentially saving Americans billions on prescription drug costs by removing extra clinical trial requirements.
Read the full article at:
Fox News →